stage IV uterine sarcoma
Showing 1 - 25 of >10,000
Metastatic Leiomyosarcoma, Metastatic Soft Tissue Sarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in United
Recruiting
- Metastatic Leiomyosarcoma
- +10 more
- Cabozantinib
- +3 more
-
Duarte, California
- +4 more
Nov 4, 2021
Collecting Blood Samples From and Without Cancer to Evaluate
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +61 more
- Questionnaire Administration
- Biospecimen Collection
- (no location specified)
Apr 12, 2022
Malignant Female Reproductive System Tumor, Stage III Cervical Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8 Trial in Duarte
Not yet recruiting
- Malignant Female Reproductive System Neoplasm
- +10 more
- Discussion
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 24, 2023
Endometrial Carcinoma, Stage 0 Fallopian Tube Cancer AJCC v7, Stage I Fallopian Tube Cancer AJCC v6 and v7 Trial in New
Withdrawn
- Endometrial Carcinoma
- +55 more
- Internet-Based Intervention
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Apr 16, 2021
Stage III Vulvar Cancer, Stage III Ovarian Cancer, Stage III Uterine Cancer Trial in Indianapolis (Intervention group triads)
Enrolling by invitation
- Stage III Vulvar Cancer
- +7 more
- Intervention group triads
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Aug 10, 2023
Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8, Clinical Stage IVB Gastric Cancer AJCC v8
Recruiting
- Clinical Stage IV Gastric Cancer AJCC v8
- +26 more
- Biopsy
- +10 more
-
Duarte, California
- +2 more
Jan 25, 2023
Metastatic Ewing Sarcoma, Metastatic Osteosarcoma, Recurrent Ewing Sarcoma Trial in France (Cabozantinib S-malate, Laboratory
Active, not recruiting
- Metastatic Ewing Sarcoma
- +9 more
- Cabozantinib S-malate
- Laboratory Biomarker Analysis
-
Bordeaux, France
- +10 more
Nov 26, 2022
Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York
Recruiting
- Locally Advanced Leiomyosarcoma
- +5 more
- Olaparib
- +3 more
-
New York, New YorkColumbia University/Herbert Irving Cancer Center
Jan 4, 2023
Stage IA Uterine Sarcoma, Stage IB Uterine Sarcoma, Stage IC Uterine Sarcoma Trial in Bronx (drug, radiation, other)
Terminated
- Stage IA Uterine Sarcoma
- +10 more
- paclitaxel
- +5 more
-
Bronx, New YorkAlbert Einstein College of Medicine
Apr 21, 2021
Pleomorphic Rhabdomyosarcoma, Stage IIB Adult Soft Tissue Sarcoma AJCC v7, Stage III Adult Soft Tissue Sarcoma AJCC v7 Trial in
Completed
- Pleomorphic Rhabdomyosarcoma
- +3 more
- Epirubicin Hydrochloride
- +5 more
-
Portland, OregonOHSU Knight Cancer Institute
Feb 23, 2022
Lung Cancer, Ovarian Cancer, Uterine Cancer Trial in United States (OmniSeq Test)
Recruiting
- Lung Cancer
- +12 more
- OmniSeq Test
-
Fort Payne, Alabama
- +7 more
Jan 16, 2023
Metastatic Malignant Tumor in the Lung, Stage IIIB NSCLC, Stage IV Adult Soft Tissue Sarcoma Trial in Buffalo (Cisplatin,
Completed
- Metastatic Malignant Neoplasm in the Lung
- +3 more
- Cisplatin
- Pharmacological Study
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Retroperitoneal Sarcoma AJCC v8 Trial in Columbus
Not yet recruiting
- Locally Advanced Leiomyosarcoma
- +6 more
- Niraparib Tosylate Monohydrate
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jul 25, 2022
Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin
Active, not recruiting
- Advanced Soft Tissue Sarcoma
- +26 more
- Doxorubicin Hydrochloride
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Jan 6, 2023
Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon
Active, not recruiting
- Metastatic Myxoid Liposarcoma
- +15 more
- Interferon Gamma-1b
- +2 more
-
Palo Alto, California
- +6 more
Aug 2, 2022
Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York
Not yet recruiting
- Locally Advanced Leiomyosarcoma
- +8 more
- Olaparib
- +3 more
- (no location specified)
Jul 6, 2022
Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma
Not yet recruiting
- Advanced Dedifferentiated Liposarcoma
- +5 more
- Palbociclib
- +5 more
- (no location specified)
Jan 11, 2023
Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in
Recruiting
- Recurrent Endometrial Carcinoma
- +12 more
- Everolimus
- +2 more
-
Houston, Texas
- +1 more
Sep 22, 2022
Malignant Female Reproductive System Tumor, Recurrent Cervical Carcinoma, Recurrent Endometrial Carcinoma Trial in Houston
Recruiting
- Malignant Female Reproductive System Neoplasm
- +24 more
- Quality-of-Life Assessment
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 6, 2022
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Locally Advanced Gastrointestinal Stromal Tumor, Locally Advanced Sarcoma, Metastatic Gastrointestinal Stromal Tumor Trial in
Recruiting
- Locally Advanced Gastrointestinal Stromal Tumor
- +7 more
- Biopsy
- +4 more
-
Duarte, California
- +17 more
Feb 2, 2023
Remote Telemonitoring of Patient-Generated Physiologic Health
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +171 more
- Patient Monitoring
- Questionnaire Administration
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 15, 2022
Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,
Recruiting
- Advanced Breast Carcinoma
- +73 more
- Atezolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
May 5, 2022
Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States (drug,
Completed
- Adult Angiosarcoma
- +3 more
- pazopanib hydrochloride
- +4 more
-
Chicago, Illinois
- +4 more
Jul 26, 2022